Matthew Onaitis - Net Worth and Insider Trading
Matthew Onaitis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Onaitis owns 2 companies in total, including Cidara Therapeutics Inc (CDTX) , and Ignyta Inc (RXDX) .
Click here to see the complete history of Matthew Onaitis’s form 4 insider trades.
Insider Ownership Summary of Matthew Onaitis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2016-07-01 | Gnrl Counsel & CFO & Secretary |
| RXDX | Ignyta Inc | 2016-01-07 | General Counsel and Secretary |
Matthew Onaitis Trading Performance
Matthew Onaitis Ownership Network
Matthew Onaitis Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Matthew Onaitis is the Gnrl Counsel & CFO & Secretary of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Matthew Onaitis made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net purchase of 108,000 shares made by Jeffrey Stein , and a net sale of 40,379 shares made by Taylor Sandison .
In summary, during the past 3 months, insiders sold 1,833 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 1,833 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 13,500 shares were bought by its insiders, resulting in a net purchase of 5,749 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
Matthew Onaitis Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Onaitis. You might contact Matthew Onaitis via mailing address: C/o Somaxon Pharmaceuticals, Inc., 10935 Vista Sorrento Parkway, Suite 250, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
